OUR MISSION

At Inflammatix, we are reimagining diagnostics

Inflammatix will create and commercialize best-in-class host-response diagnostics to resolve major clinical and public health challenges.

Better patient care is at the core of what we do. We achieve better patient care through our innovative approach to developing diagnostics–our tests read the patient’s immune system to help us understand the cause of infection and the degree of its severity. Armed with this knowledge, the clinician can treat the patient appropriately and within minutes.

Precision medicine on demand

There is a critical unmet need for quickly and accurately characterizing infections in patients who are acutely ill. Our expert bioinformatics and assay development teams are building a host response-based diagnostics pipeline that includes tests for acute infection and sepsis, emerging infectious diseases, autoimmune diseases, tropical infections, transplant rejection and other conditions.

We are initially focused on developing tests for acute bacterial infections, viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University.

Inflammatix-diagnostics

Leadership

Tim Sweeney, MD, PhD
Tim Sweeney, MD, PhDCo-Founder and CEO
Bio
Jonathan Romanowsky
Jonathan RomanowskyCo-Founder and Chief Business Officer
Bio
Oliver Liesenfeld, MD
Oliver Liesenfeld, MDChief Medical Officer
Bio
Joao Fonseca, PhD
Joao Fonseca, PhDChief Technology Officer
Bio
Amy Boyle
Amy BoyleChief Operating Officer
Bio
Ljubomir Buturovic, PhD
Ljubomir Buturovic, PhDVice President of Machine Learning
Bio
Yudong He, PhD, MBA
Yudong He, PhD, MBAVice President of Computational Biology
Bio
Nina Menezes, PhD
Nina Menezes, PhDVice President of Marketing
Bio
Pamela Lambert, MS, PMP
Pamela Lambert, MS, PMPVice President of Program Management & Design Assurance
Bio
Paul Fleming, PhD
Paul Fleming, PhDVice President of Engineering
Bio
Howard Solovei
Howard SoloveiVice President Finance and Business Operations
Bio
Diana Lane
Diana LaneVice President Quality Assurance and Regulatory Affairs
Bio
Purvesh Khatri, PhD
Purvesh Khatri, PhDCo-Founder and Scientific Advisor
Bio

Board of Directors

Tim Sweeney, MD, PhD
Tim Sweeney, MD, PhDCo-Founder and CEO

Bio

Bio
Steve Tablak
Steve TablakFormer Chairman and CEO, GeneWeave

Bio

Bio
Michael Rubin, MD, PhD
Michael Rubin, MD, PhDFounder and CEO at Northpond Ventures

Bio

Bio
Ken Bahk, PhD
Ken Bahk, PhDCEO of Lakewood Holdings

Bio

Bio
Justin Kao
Justin KaoPartner at Khosla Ventures

Bio

Bio

Advisors

Jesús Bermejo-Martin, MD, PhD
Jesús Bermejo-Martin, MD, PhDPrincipal Investigator, BioSepsis

Bio

Bio
Hector Wong, MD
Hector Wong, MDProfessor of Pediatrics

Bio

Bio
Nathan A Ledeboer
Nathan A LedeboerProfessor and Vice Chair of Pathology

Bio

Bio
Jim Ducharme
Jim DucharmeClinical Professor of Medicine

Bio

Bio

Investors

Inflammatix investors include the following groups:

Partner with Us!

Inflammatix is establishing partnerships with diagnostic instrument, companion therapeutic and commercial distribution companies across the globe. Contact us at info@inflammatix.com to explore collaboration opportunities.

Our current partners include Genentech, DRIVe, BARDA and DARPA

Awards

Inflammatix is recognized for our accomplishments and promise

2021 SCCM Gold Snapshot Award for the 50th Critical Care Congress

Tracxn Emerging Startups 2021: Top Diagnostics Tech Startups

2020 MedTech Innovator Top 50 Medtech Startups

2019 FierceMedTech Fierce 15 Company

2019 AACC Disruptive Technology and Audience Choice Awards

2017 ISF Best Clinical Abstract Award

Stay in touch with social updates:
Find out the latest news.

Follow us on Twitter
Follow us on LinkedIn